Related Experiment Video
Updated: May 3, 2026
08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
7.3K
Sample and data sharing barriers in biobanking: consent, committees, and compromises.
Flora Colledge1, Kirsten Persson1, Bernice Elger1
1Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
Annals of Diagnostic Pathology
|February 4, 2014
Summary
Biobanking stakeholders face challenges in sample sharing consent. While general consent is often used, ethics committees
Area of Science:
- Biobanking and Sample Management
- Research Ethics
- Informed Consent
Background:
- Effective biobanking relies on efficient sample and data exchange.
- Donor consent is paramount for sample sharing, presenting ethical and logistical challenges.
- Stakeholders must navigate options for obtaining consent for sample utilization.
Purpose of the Study:
- To explore Swiss biobanking stakeholders' perspectives on consent models for sample sharing.
- To investigate the role and perceived efficiency of ethics committees in authorizing sample sharing.
- To identify potential improvements for consent processes in biobanking.
Main Methods:
- Conducted 36 semistructured qualitative interviews with biobanking stakeholders.
- Focused on three consent options: general consent, re-consent, and consent waiver.
- Examined the involvement and impact of ethics committees.
Main Results:
- General consent is widely used, despite some reservations from stakeholders and ethics committees.
- Ethics committee processes are frequently perceived as time-consuming, cumbersome, and demanding for donors.
- Lack of awareness regarding donor preferences and guidelines may hinder justified decision-making.
Conclusions:
- Greater understanding of donor opinions and clearer guidelines can improve biobanking consent processes.
- Differentiating consent procedures for future versus existing samples may optimize research.
- Streamlining ethics committee interactions is crucial for efficient biobanking operations.
Related Concept Videos
01:02Sample Handling
3.0K
Transportation of samples from the collection point to the laboratory, as well as storage and preservation techniques, are crucial for maintaining sample integrity and ensuring accurate and reliable test results.
Samples should be transported carefully from collection points to the laboratory. They should be properly sealed and clearly labeled to prevent cross-contamination. To preserve the sample integrity, optimal temperature conditions during transport are essential. This could involve using...
Samples should be transported carefully from collection points to the laboratory. They should be properly sealed and clearly labeled to prevent cross-contamination. To preserve the sample integrity, optimal temperature conditions during transport are essential. This could involve using...
3.0K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
01:56Ethics in Research
23.7K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.7K
01:13Bioequivalence studies: Biowaivers
430
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
430
01:25Ethical Standards I
1.5K
The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
1.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627